Pharmaceutical giant slashes insulin prices after pressure from government and consumers

More than seven million Americans rely on insulin and prices for the life-saving drug have sky-rocketed. With pressure mounting on pharmaceutical companies to address the cost of diabetes care, Eli Lilly announced it’s cutting prices for its most popular insulin products by 70% and capping out-of-pocket costs at $35 a month. Bram Sable-Smith of Kaiser Health News joined Geoff Bennett to discuss.

Stream your PBS favorites with the PBS app: ❤️情人节美甲💅教程#20nails://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: ❤️情人节美甲💅教程#20nails://bit.ly/2HfsCD6

Follow us:
TikTok: ❤️情人节美甲💅教程#20nails://www.tiktok.com/@pbsnews
推特: 在家DIY的最佳美甲://www.twitter.com/newshour
Instagram: 在家DIY的最佳美甲://www.instagram.com/newshour
Facebook: 在家DIY的最佳美甲://www.pbs.org/newshour

订阅:
PBS NewsHour podcasts: ❤️情人节美甲💅教程#20nails://www.pbs.org/newshour/podcasts
Newsletters: ❤️情人节美甲💅教程#20nails://www.pbs.org/newshour/subscribe